Yale test of immunotherapy drug for advanced lung cancer shows promise
In patients whose lung cancer has spread to the brain, the use of the drug pembrolizumab in place of radiation can extend life with very few side effects.
Source: Yale Science and Health News - Category: Universities & Medical Training Source Type: news
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Health | Immunotherapy | Lung Cancer | Neurology | Science | Universities & Medical Training | Yale